Home › Hand Injuries and Disorders › NCT05837286

Conservative Treatment of Trigger Finger

Conservative Treatment of Trigger Finger: Outcomes of a Randomized Controlled Trial

Who can join

Ages 18 to 100 · All sexes

Inclusion Criteria:

* Individuals 18 years old or older are included
* Patients with trigger finger, aka stenosing flexor tenosynovitis
* Status post receiving cortisone injection of the affected digit(s)

Exclusion Criteria:

* Any records flagged with break the glass or research opt out
* Patients with rheumatoid arthritis
* Patients with a history of traumatic injury to the hand
* Cognitive or behavioral problems which would preclude informed consent
* Unable to speak and understand English

About the study

This study is to analyze the effectiveness of a nighttime extension orthosis after receiving a cortisone injection for the treatment of trigger finger to improve pain and restore functional outcomes. The investigators hypothesize that the extension orthosis will improve pain and functional outcomes compared to those without a digital night extension orthosis in those with trigger finger at 12 weeks from the injection.

What is being tested

• Oval-8 ® Orthosis (device)
• Cortisone injection only (other)

Sponsor: Cedars-Sinai Medical Center · Participants: 146 · Started: Aug 1, 2023

Contact the study team

• Theodore Brown, BS · Phone: 800-700-6424

Official record on ClinicalTrials.gov — NCT05837286

Locations in the U.S.

Conditions

• Hand Injuries and Disorders

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.